In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

Zurcher Kantonalbank Zurich Cantonalbank grew its stake in UiPath Inc. (NYSE:PATH – Free Report) by 57.5% in the 4th quarter, ...

Steward Partners Investment Advisory LLC grew its position in shares of UiPath Inc. (NYSE:PATH – Free Report) by 99.8% during ...

UiPath (NYSE: PATH) reported quarterly financial results that disappointed stock market investors. Start Your Mornings ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

UiPath (NYSE:PATH) saw its stock plummet over 14% intra-day today after delivering a disappointing revenue forecast for ...

The semiconductor company named Lip-Bu Tan, a former board m ...

Learn more about whether Manhattan Associates, Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Open Text Corporation or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested the latest economic data and Trump's response to Canada and EU tariffs. The S&P 500 closed in correction territory.

Intel shares are jumping more than 10% as investors welcome the news that Lip-Bu Tan would be the struggling chip giant's [new chief executive]( ...

US stocks fell on Thursday, with the S&P 500 (^GSPC) officially entering into correction territory, as economic concerns grew and investors digested the latest inflation data, President Trump's trade ...